Publications by authors named "Emilio Borrajo Brunete"
Article Synopsis
- Strongyloidiasis is a parasitic disease that poses significant risks, especially to individuals with weakened immune systems, and is prevalent among both migrants and the native population in the Mediterranean region.
- A study conducted from 2019 to 2022 assessed various screening methods for the disease among a diverse group of participants, revealing a confirmed infection rate of 8.3%.
- The research found that stool PCR tests were more effective than serological screening alone, which missed a notable percentage of cases, and identified specific risk factors like elevated IgE levels and Latin American origin associated with the disease.
Objective: Readmission for COVID-19 is associated with high mortality, saturation of health services, and high costs. This study aimed to assess the incidence and risk factors of readmissions in COVID-19 patients in a regional hospital of Spain from February 2020 to March 2021.
Methods: A retrospective cohort study describing the characteristics of adult patients readmitted within thirty days of discharge after being infected with SARS-CoV-2 was carried out.
Introduction: There is negligible evidence on the efficacy of ivermectin for treating COVID-19 pneumonia. This study aimed to assess the efficacy of ivermectin for pre-emptively treating hyperinfection syndrome in order to reduce mortality and the need for respiratory support in patients hospitalized for COVID-19.
Methods: This single-center, observational, retrospective study included patients admitted with COVID-19 pneumonia at Hospital Vega Baja from 23 February 2020 to 14 March 2021.
Background: Strongyloidiasis is a parasitic disease with global prevalence. In Spain, autochthonous cases are concentrated in the Mediterranean basin. We aimed to analyze clinical and epidemiological characteristics of infection in Vega Baja del Segura (Spain), comparing autochthonous versus imported cases.
View Article and Find Full Text PDF